Signatera Data Links ctDNA Clearance to Long-Term Survival in Four Cancers
New data presented at SITC include a real-world analysis of Signatera monitoring during first-line immunotherapy. The report says ctDNA clearance is associated with long-term survival across four metastatic cancers.